Table 1.
Variable | % (N) or Mean (SD) | Available N |
---|---|---|
Uses nicotine replacement therapy (NRT) at baseline | 38.0% (333) | 877 |
Uses NRT at follow-up | 33.8% (300) | 887 |
Typology of NRT adoption at follow-up | 868 | |
Sustained adopter | 21.4% (186) | |
Recent adopter | 12.1% (105) | |
Discontinuer | 16.2% (141) | |
Non-adopter | 50.2% (436) | |
Baseline Variables | ||
Organizational type | 897 | |
Publicly funded treatment centers | 33.3% (299) | |
Privately funded treatment centers | 35.8% (321) | |
Therapeutic communities | 30.9% (277) | |
Government-owned | 11.9% (107) | 897 |
For-profit | 13.6% (122) | 897 |
Based in a hospital | 21.1% (189) | 897 |
Levels of care | 892 | |
Inpatient/residential-only | 28.7% (256) | |
Mixture of inpatient/residential and outpatient | 38.0% (339) | |
Outpatient-only | 33.3% (297) | |
12-step meeting attendance is required during treatment | 70.3% (630) | 896 |
Organizational size (number of full-time equivalent employees) | 34.1 (53.9) | 879 |
Access to Physicians | 878 | |
At least one physician on staff | 36.2% (318) | |
At least one physician on contract | 33.3% (292) | |
No access to physicians | 30.5% (268) | |
Currently uses bupropion-SR | 29.8% (262) | 878 |
Teaches smoking cessation techniques to patients | 45.0% (403) | 896 |
Follow-up Variables | ||
Has adopted bundle of smoking cessation-related intake procedures | 14.6% (127) | 868 |
Offers a formal counseling-based smoking cessation program | 17.1% (153) | 895 |
Currently uses bupropion-SR | 14.8% (129) | 874 |
Currently uses varenicline | 6.2% (54) | 870 |
Note: Percentages may not sum to 100% due to rounding.